How to Survive FDA Battles and Boardroom Drama - with Sabine Bois
AUG 27, 202554 MIN
How to Survive FDA Battles and Boardroom Drama - with Sabine Bois
AUG 27, 202554 MIN
Description
<p>This episode of the Crux of Medtech features Sabine Bois, the former CEO of Occlutech.</p><p>Sabine is a medtech leader whose career spans founding startups, steering a company through bankruptcy, driving IPO prep, and ultimately leading as CEO.</p><p>Her story is raw, unfiltered, and filled with lessons about resilience, leadership, and navigating the brutal realities of medtech.</p><p><strong>Key Topics:</strong></p><ul><li><p>Sabine’s leap from small-town Germany to founding her first medtech startup</p></li><li><p>Navigating bankruptcy and rebuilding into a successful acquisition</p></li><li><p>The commercial lessons that reshaped her career trajectory</p></li><li><p>Transition from CFO to CEO at Occlutech during global litigation and IPO prep</p></li><li><p>The turbulence behind IPO readiness, audits, and roadshows</p></li><li><p>Why passion and relentlessness matter more than resources<br></p></li></ul><p><strong>Related Insights:</strong></p><ul><li><p>Failure wasn’t an option for the Wright brothers or for startups</p></li><li><p>The CEO’s ability to adapt their pitch can make or break funding</p></li><li><p>Timing and market cycles are often as critical as technology</p></li><li><p>Strategics are approachable but require careful balance in what you share<br></p></li></ul><p><strong>Core Challenges:</strong></p><ul><li><p>Surviving insolvency while protecting IP and technology</p></li><li><p>Learning that a CEO’s first responsibility is revenue, not admin</p></li><li><p>Facing last-minute IPO derailments and high-stakes investor negotiations</p></li><li><p>Adjusting from European regulatory norms to the strict demands of the FDA</p></li><li><p>Raising funds in today’s tougher, profitability-driven investor landscape</p></li></ul><p>Tune in now to hear Sabine’s unfiltered journey through medtech’s toughest challenges and what it really takes to lead with resilience.</p><p><br></p><p>The Crux of MedTech podcast is brought to you by Cruxx, a specialist surgical robotics recruitment agency. </p><p><br></p><p>To learn more about Cruxx,<a href="https://www.thisiscruxx.com/"> click here.</a></p><p><br></p><p>A big thank you to our sponsors on this season of the podcast; </p><p><br></p><p><a href="https://www.linkedin.com/company/the-technology-partnership/">TTP plc</a> With a 35-year track record, TTP excels in turning innovative ideas into market-ready solutions. Their team of 300+ experts deliver breakthrough solutions in areas ranging from endoluminal robotics and navigation systems to ultrasound imaging. Whether you're a startup or a multinational, <a href="https://www.linkedin.com/company/the-technology-partnership/">TTP plc</a> can accelerate your development with the latest technologies. Learn more at <a href="http://ttp.com/">TTP.com</a></p><p><br></p><p>&</p><p><br></p><p><a href="www.kuka.com/healthcare">KUKA</a> is a global leader in robotics with over 25 years of experience partnering with medtech companies on their journey to market. Their reputation is built on robust technology, reliability and long term collaboration and being more than just a supplier.</p><p><br></p><p>KUKA provides trusted support throughout the product life cycle, from development to integration and beyond. </p><p>Find out more at <a href="www.kuka.com/healthcare">kuka.com/healthcare</a></p>